EN
GlobeNewsInfo Logo
Home / Technology / LG Chem pivots to high-value tech materials with KRW 15 trillion R&D commitment
Technology

LG Chem pivots to high-value tech materials with KRW 15 trillion R&D commitment

Korea (South) | July 02, 2026
Federal Reserve Building

South Korean chemical major LG Chem has unveiled a long-term strategic overhaul, pledging KRW 15 trillion in research and development funding through 2035. The initiative shifts the company's core focus away from traditional commodity chemicals toward AI-driven, advanced materials for high-growth technological sectors.

LG Chem announced a strategic repositioning designed to counter global oversupply and declining margins within the legacy chemical market. The company will allocate 70% of its newly announced KRW 15 trillion research and development budget directly into specialized growth divisions, including semiconductor infrastructure, mobility systems, and robotics materials. Headquartered in South Korea, LG Chem is a diversified chemical manufacturer expanding its portfolio into advanced electronics, automotive materials, and life sciences. To accelerate this transition, the firm recently established a dedicated business development unit operating under direct chief executive oversight.

This massive reallocation of capital underscores a broader trend of industrial chemical firms decoupling from cyclical commodity markets to insulate themselves from intensifying regional price competition. By targeting a double-digit operating margin by 2030, the organization plans to transition into an integrated solutions provider that co-designs manufacturing processes and custom performance metrics alongside its corporate clients, moving away from volume-based material supplying.

The electronic materials segment is projected to scale to KRW 2 trillion by 2030, heavily favoring advanced packaging technologies, low-dielectric substances, thermal management solutions, and glass substrates. Concurrently, the mobility and robotics arms will expand past electric vehicle components into structural robot parts, precision actuation systems, and specialized bonding agents, while its pharmaceutical branch expands clinical pipelines for oncology drugs via strategic mergers and international partnerships.

For global supply chains and institutional investors, this transformation signals an evolving landscape where technical material performance and proprietary chemical formulations create high entry barriers. The company intendeds to fund complementary mergers and acquisitions within its capital constraints to fortify its international market share across these specialized technology sectors.

About GlobeNewsInfo

GlobeNewsInfo.com is a business news platform providing latest updates on global business developments, projects, and contract opportunities across diverse sectors and regions. The platform is designed to serve as a trusted source of information for companies, investors, and professionals worldwide.

More on Technology

Latest Business News

Just In